We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRPL:NASDAQPurple Innovation, Inc. Analysis

Data as of 2026-06-01 - not real-time

$0.40

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Purple Innovation is trading well below its 20‑day SMA (0.45) and 200‑day SMA (0.76), indicating a prolonged downtrend, but the MACD line has just crossed above its signal line, offering a tentative bullish signal. RSI is near 32, suggesting the stock is oversold and may be primed for a short‑term bounce toward the identified resistance at $0.544. Volume has been decreasing, and 30‑day volatility exceeds 80%, underscoring a fragile price environment. The company’s fundamentals are weak: negative gross, operating and profit margins, a cash deficit of over $7 million in operating cash flow, and a debt load of $211 million against just $25 million in cash. Valuation metrics such as a price‑to‑sales ratio of 0.09 and a negative price‑to‑book hint at deep discounting, yet the negative earnings and book value raise concerns about sustainability. A recent insider purchase of 60,000 shares by the CFO adds a modest confidence signal, but it is modest relative to the broader financial distress.
Given the bearish technical backdrop, high volatility, and a beta that suggests moderate market sensitivity, the stock faces elevated risk. The consumer‑cyclical furnishings sector is currently pressured, and the lack of dividend or cash generation further limits defensive appeal. While the technical oversold condition and insider buying could spark a brief rally, the underlying operational challenges and heavy debt imply that any recovery would require a substantive turnaround in revenue growth and cash generation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Technical oversold condition (RSI ~32)
  • Support level near $0.393
  • CFO insider purchase signaling limited confidence

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Persistent negative margins and cash burn
  • High debt relative to cash reserves
  • Sector pressure on consumer discretionary spending

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Ongoing operating losses and negative book value
  • Elevated volatility and weak liquidity
  • Lack of dividend and unclear path to profitability

Key Metrics & Analysis

Financial Health

Revenue Growth-8.10%
Profit Margin-13.65%
P/E Ratio-2.0
ROA-7.93%
P/B Ratio-0.7
Op. Cash Flow$-7771000
Free Cash Flow$-20060750

Technical Analysis

TrendBearish
RSI31.8
Support$0.39
Resistance$0.54
MA 20$0.45
MA 50$0.56
MA 200$0.76
MACDBullish
VolumeDecreasing
Fear & Greed Index94.07

Valuation

Target Price$0.83
Upside/Downside105.58%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.77
Volatility83.18%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.